Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

Authors: Yusuke Okuma, Yukio Hosomi, Shingo Miyamoto, Masahiko Shibuya, Tatsuru Okamura, Tsunekazu Hishima

Published in: BMC Cancer | Issue 1/2016

Login to get access

Excerpt

Following publication of this work [1] the authors noticed a mistake within the article’s competing interests section. The correct competing interests section is provided below. …
Metadata
Title
Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma
Authors
Yusuke Okuma
Yukio Hosomi
Shingo Miyamoto
Masahiko Shibuya
Tatsuru Okamura
Tsunekazu Hishima
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2309-y

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine